APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Drugs and Supplement

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Equine Drugs and Supplement Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchEquine Drugs and Supplement Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Drugs and Supplement Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Equine Drugs and Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Drugs and Supplement Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Drugs and Supplement Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Equine Drugs and Supplement market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Equine Drugs and Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Equine Drugs and Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Equine Drugs and Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Equine Drugs and Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Equine Drugs and Supplement include Zoetis, Novartis Animal Health, Merck Animal Health, Bayer Animal Health, Merial, Elanco (Eli Lilly) and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Equine Drugs and Supplement, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Equine Drugs and Supplement, also provides the sales of main regions and countries. Of the upcoming market potential for Equine Drugs and Supplement, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Equine Drugs and Supplement sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Equine Drugs and Supplement market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Equine Drugs and Supplement sales, projected growth trends, production technology, application and end-user industry.

Equine Drugs and Supplement Segment by Company

Zoetis

Novartis Animal Health

Merck Animal Health

Bayer Animal Health

Merial

Elanco (Eli Lilly)

Boehringer Ingelheim

Equine Drugs and Supplement Segment by Type

Stable Isotope

Radioisotope

Equine Drugs and Supplement Segment by Application

Hospital

Laboratory

Others

Equine Drugs and Supplement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Drugs and Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Drugs and Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Drugs and Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Equine Drugs and Supplement in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Equine Drugs and Supplement manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equine Drugs and Supplement sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Equine Drugs and Supplement Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stable Isotope Major Manufacturers Table 3. Radioisotope Major Manufacturers Table 4. Global Equine Drugs and Supplement Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Laboratory Major Manufacturers Table 7. Others Major Manufacturers Table 8. Equine Drugs and Supplement Industry Trends Table 9. Equine Drugs and Supplement Industry Drivers Table 10. Equine Drugs and Supplement Industry Opportunities and Challenges Table 11. Equine Drugs and Supplement Industry Restraints Table 12. Global Equine Drugs and Supplement Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Equine Drugs and Supplement Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Equine Drugs and Supplement Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Equine Drugs and Supplement Revenue Market Share by Region (2021-2026) Table 16. Global Equine Drugs and Supplement Revenue Market Share by Region (2027-2032) Table 17. Global Equine Drugs and Supplement Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Equine Drugs and Supplement Sales by Region (2021-2026) & (k units) Table 19. Global Equine Drugs and Supplement Sales by Region (2027-2032) & (k units) Table 20. Global Equine Drugs and Supplement Sales Market Share by Region (2021-2026) Table 21. Global Equine Drugs and Supplement Sales Market Share by Region (2027-2032) Table 22. Global Equine Drugs and Supplement Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Equine Drugs and Supplement Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Equine Drugs and Supplement Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Equine Drugs and Supplement Sales Market Share by Manufacturers (2021-2026) Table 26. Global Equine Drugs and Supplement Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Equine Drugs and Supplement Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Equine Drugs and Supplement Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Equine Drugs and Supplement Manufacturers, Product Type & Application Table 30. Global Equine Drugs and Supplement Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Equine Drugs and Supplement by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Equine Drugs and Supplement Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Equine Drugs and Supplement Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Equine Drugs and Supplement Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2026) Table 37. Global Equine Drugs and Supplement Revenue Market Share by Type (2027-2032) Table 38. Global Equine Drugs and Supplement Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Equine Drugs and Supplement Sales by Type (2021-2026) & (k units) Table 40. Global Equine Drugs and Supplement Sales by Type (2027-2032) & (k units) Table 41. Global Equine Drugs and Supplement Sales Market Share by Type (2021-2026) Table 42. Global Equine Drugs and Supplement Sales Market Share by Type (2027-2032) Table 43. Global Equine Drugs and Supplement Price by Type (2021-2026) & (US$/unit) Table 44. Global Equine Drugs and Supplement Price by Type (2027-2032) & (US$/unit) Table 45. Global Equine Drugs and Supplement Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Equine Drugs and Supplement Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Equine Drugs and Supplement Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Equine Drugs and Supplement Revenue Market Share by Application (2021-2026) Table 49. Global Equine Drugs and Supplement Revenue Market Share by Application (2027-2032) Table 50. Global Equine Drugs and Supplement Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Equine Drugs and Supplement Sales by Application (2021-2026) & (k units) Table 52. Global Equine Drugs and Supplement Sales by Application (2027-2032) & (k units) Table 53. Global Equine Drugs and Supplement Sales Market Share by Application (2021-2026) Table 54. Global Equine Drugs and Supplement Sales Market Share by Application (2027-2032) Table 55. Global Equine Drugs and Supplement Price by Application (2021-2026) & (US$/unit) Table 56. Global Equine Drugs and Supplement Price by Application (2027-2032) & (US$/unit) Table 57. Zoetis Company Information Table 58. Zoetis Business Overview Table 59. Zoetis Equine Drugs and Supplement Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Zoetis Equine Drugs and Supplement Product Portfolio Table 61. Zoetis Recent Development Table 62. Novartis Animal Health Company Information Table 63. Novartis Animal Health Business Overview Table 64. Novartis Animal Health Equine Drugs and Supplement Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Novartis Animal Health Equine Drugs and Supplement Product Portfolio Table 66. Novartis Animal Health Recent Development Table 67. Merck Animal Health Company Information Table 68. Merck Animal Health Business Overview Table 69. Merck Animal Health Equine Drugs and Supplement Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Merck Animal Health Equine Drugs and Supplement Product Portfolio Table 71. Merck Animal Health Recent Development Table 72. Bayer Animal Health Company Information Table 73. Bayer Animal Health Business Overview Table 74. Bayer Animal Health Equine Drugs and Supplement Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Bayer Animal Health Equine Drugs and Supplement Product Portfolio Table 76. Bayer Animal Health Recent Development Table 77. Merial Company Information Table 78. Merial Business Overview Table 79. Merial Equine Drugs and Supplement Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Merial Equine Drugs and Supplement Product Portfolio Table 81. Merial Recent Development Table 82. Elanco (Eli Lilly) Company Information Table 83. Elanco (Eli Lilly) Business Overview Table 84. Elanco (Eli Lilly) Equine Drugs and Supplement Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolio Table 86. Elanco (Eli Lilly) Recent Development Table 87. Boehringer Ingelheim Company Information Table 88. Boehringer Ingelheim Business Overview Table 89. Boehringer Ingelheim Equine Drugs and Supplement Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Boehringer Ingelheim Equine Drugs and Supplement Product Portfolio Table 91. Boehringer Ingelheim Recent Development Table 92. North America Equine Drugs and Supplement Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Equine Drugs and Supplement Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Equine Drugs and Supplement Sales by Type (2021-2026) & (k units) Table 95. North America Equine Drugs and Supplement Sales by Type (2027-2032) & (k units) Table 96. North America Equine Drugs and Supplement Sales Price by Type (2021-2026) & (US$/unit) Table 97. North America Equine Drugs and Supplement Sales Price by Type (2027-2032) & (US$/unit) Table 98. North America Equine Drugs and Supplement Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Equine Drugs and Supplement Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Equine Drugs and Supplement Sales by Application (2021-2026) & (k units) Table 101. North America Equine Drugs and Supplement Sales by Application (2027-2032) & (k units) Table 102. North America Equine Drugs and Supplement Sales Price by Application (2021-2026) & (US$/unit) Table 103. North America Equine Drugs and Supplement Sales Price by Application (2027-2032) & (US$/unit) Table 104. North America Equine Drugs and Supplement Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Equine Drugs and Supplement Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Equine Drugs and Supplement Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Equine Drugs and Supplement Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 108. North America Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 109. North America Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 110. North America Equine Drugs and Supplement Sales Price by Country (2021-2026) & (US$/unit) Table 111. North America Equine Drugs and Supplement Sales Price by Country (2027-2032) & (US$/unit) Table 112. United States Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 113. Canada Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 114. Mexico Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 115. Europe Equine Drugs and Supplement Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Equine Drugs and Supplement Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Equine Drugs and Supplement Sales by Type (2021-2026) & (k units) Table 118. Europe Equine Drugs and Supplement Sales by Type (2027-2032) & (k units) Table 119. Europe Equine Drugs and Supplement Sales Price by Type (2021-2026) & (US$/unit) Table 120. Europe Equine Drugs and Supplement Sales Price by Type (2027-2032) & (US$/unit) Table 121. Europe Equine Drugs and Supplement Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Equine Drugs and Supplement Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Equine Drugs and Supplement Sales by Application (2021-2026) & (k units) Table 124. Europe Equine Drugs and Supplement Sales by Application (2027-2032) & (k units) Table 125. Europe Equine Drugs and Supplement Sales Price by Application (2021-2026) & (US$/unit) Table 126. Europe Equine Drugs and Supplement Sales Price by Application (2027-2032) & (US$/unit) Table 127. Europe Equine Drugs and Supplement Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Equine Drugs and Supplement Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Equine Drugs and Supplement Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Equine Drugs and Supplement Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 131. Europe Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 132. Europe Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 133. Europe Equine Drugs and Supplement Sales Price by Country (2021-2026) & (US$/unit) Table 134. Europe Equine Drugs and Supplement Sales Price by Country (2027-2032) & (US$/unit) Table 135. Germany Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 136. France Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 137. U.K. Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 138. Italy Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 139. Russia Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 140. Spain Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 143. Sweden Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 144. Poland Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 145. China Equine Drugs and Supplement Revenue by Type (2021-2026) & (US$ Million) Table 146. China Equine Drugs and Supplement Revenue by Type (2027-2032) & (US$ Million) Table 147. China Equine Drugs and Supplement Sales by Type (2021-2026) & (k units) Table 148. China Equine Drugs and Supplement Sales by Type (2027-2032) & (k units) Table 149. China Equine Drugs and Supplement Sales Price by Type (2021-2026) & (US$/unit) Table 150. China Equine Drugs and Supplement Sales Price by Type (2027-2032) & (US$/unit) Table 151. China Equine Drugs and Supplement Revenue by Application (2021-2026) & (US$ Million) Table 152. China Equine Drugs and Supplement Revenue by Application (2027-2032) & (US$ Million) Table 153. China Equine Drugs and Supplement Sales by Application (2021-2026) & (k units) Table 154. China Equine Drugs and Supplement Sales by Application (2027-2032) & (k units) Table 155. China Equine Drugs and Supplement Sales Price by Application (2021-2026) & (US$/unit) Table 156. China Equine Drugs and Supplement Sales Price by Application (2027-2032) & (US$/unit) Table 157. Asia Equine Drugs and Supplement Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Equine Drugs and Supplement Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Equine Drugs and Supplement Sales by Type (2021-2026) & (k units) Table 160. Asia Equine Drugs and Supplement Sales by Type (2027-2032) & (k units) Table 161. Asia Equine Drugs and Supplement Sales Price by Type (2021-2026) & (US$/unit) Table 162. Asia Equine Drugs and Supplement Sales Price by Type (2027-2032) & (US$/unit) Table 163. Asia Equine Drugs and Supplement Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Equine Drugs and Supplement Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Equine Drugs and Supplement Sales by Application (2021-2026) & (k units) Table 166. Asia Equine Drugs and Supplement Sales by Application (2027-2032) & (k units) Table 167. Asia Equine Drugs and Supplement Sales Price by Application (2021-2026) & (US$/unit) Table 168. Asia Equine Drugs and Supplement Sales Price by Application (2027-2032) & (US$/unit) Table 169. Asia Equine Drugs and Supplement Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Equine Drugs and Supplement Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Equine Drugs and Supplement Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Equine Drugs and Supplement Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 173. Asia Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 174. Asia Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 175. Asia Equine Drugs and Supplement Sales Price by Country (2021-2026) & (US$/unit) Table 176. Asia Equine Drugs and Supplement Sales Price by Country (2027-2032) & (US$/unit) Table 177. Japan Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 178. South Korea Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 179. India Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 180. Australia Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Equine Drugs and Supplement Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Equine Drugs and Supplement Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Equine Drugs and Supplement Sales by Type (2021-2026) & (k units) Table 186. SAMEA Equine Drugs and Supplement Sales by Type (2027-2032) & (k units) Table 187. SAMEA Equine Drugs and Supplement Sales Price by Type (2021-2026) & (US$/unit) Table 188. SAMEA Equine Drugs and Supplement Sales Price by Type (2027-2032) & (US$/unit) Table 189. SAMEA Equine Drugs and Supplement Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Equine Drugs and Supplement Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Equine Drugs and Supplement Sales by Application (2021-2026) & (k units) Table 192. SAMEA Equine Drugs and Supplement Sales by Application (2027-2032) & (k units) Table 193. SAMEA Equine Drugs and Supplement Sales Price by Application (2021-2026) & (US$/unit) Table 194. SAMEA Equine Drugs and Supplement Sales Price by Application (2027-2032) & (US$/unit) Table 195. SAMEA Equine Drugs and Supplement Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Equine Drugs and Supplement Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Equine Drugs and Supplement Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Equine Drugs and Supplement Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 199. SAMEA Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 200. SAMEA Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 201. SAMEA Equine Drugs and Supplement Sales Price by Country (2021-2026) & (US$/unit) Table 202. SAMEA Equine Drugs and Supplement Sales Price by Country (2027-2032) & (US$/unit) Table 203. Brazil Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 204. Argentina Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 205. Chile Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 206. Colombia Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 207. Peru Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 209. Israel Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 210. UAE Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 211. Turkey Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 212. Iran Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 213. Egypt Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Equine Drugs and Supplement Distributors List Table 217. Equine Drugs and Supplement Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Equine Drugs and Supplement Image Figure 2. Global Equine Drugs and Supplement Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Drugs and Supplement Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stable Isotope Image Figure 5. Radioisotope Image Figure 6. Global Equine Drugs and Supplement Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Equine Drugs and Supplement Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Laboratory Image Figure 10. Others Image Figure 11. Global Equine Drugs and Supplement Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Figure 13. Global Equine Drugs and Supplement Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Equine Drugs and Supplement Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Equine Drugs and Supplement Revenue Market Share by Region (2021-2032) Figure 16. Global Equine Drugs and Supplement Sales (2021-2032) & (k units) Figure 17. Global Equine Drugs and Supplement Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Equine Drugs and Supplement Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Equine Drugs and Supplement Sales YoY (2021-2032) & (k units) Figure 20. Europe Equine Drugs and Supplement Sales YoY (2021-2032) & (k units) Figure 21. China Equine Drugs and Supplement Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Equine Drugs and Supplement Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Equine Drugs and Supplement Sales YoY (2021-2032) & (k units) Figure 24. Global Equine Drugs and Supplement Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Equine Drugs and Supplement Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Equine Drugs and Supplement Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Equine Drugs and Supplement Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2032) Figure 30. Global Equine Drugs and Supplement Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Equine Drugs and Supplement Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Equine Drugs and Supplement Sales Market Share by Type (2021-2032) Figure 33. Global Equine Drugs and Supplement Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Equine Drugs and Supplement Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Equine Drugs and Supplement Revenue Market Share by Application (2021-2032) Figure 36. Global Equine Drugs and Supplement Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Equine Drugs and Supplement Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Equine Drugs and Supplement Sales Market Share by Application (2021-2032) Figure 39. North America Equine Drugs and Supplement Revenue Share by Type (2021-2032) Figure 40. North America Equine Drugs and Supplement Sales Share by Type (2021-2032) Figure 41. North America Equine Drugs and Supplement Revenue Share by Application (2021-2032) Figure 42. North America Equine Drugs and Supplement Sales Share by Application (2021-2032) Figure 43. North America Equine Drugs and Supplement Revenue Share by Country (2021-2032) Figure 44. North America Equine Drugs and Supplement Sales Share by Country (2021-2032) Figure 45. Europe Equine Drugs and Supplement Revenue Share by Type (2021-2032) Figure 46. Europe Equine Drugs and Supplement Sales Share by Type (2021-2032) Figure 47. Europe Equine Drugs and Supplement Revenue Share by Application (2021-2032) Figure 48. Europe Equine Drugs and Supplement Sales Share by Application (2021-2032) Figure 49. Europe Equine Drugs and Supplement Revenue Share by Country (2021-2032) Figure 50. Europe Equine Drugs and Supplement Sales Share by Country (2021-2032) Figure 51. China Equine Drugs and Supplement Revenue Share by Type (2021-2032) Figure 52. China Equine Drugs and Supplement Sales Share by Type (2021-2032) Figure 53. China Equine Drugs and Supplement Revenue Share by Application (2021-2032) Figure 54. China Equine Drugs and Supplement Sales Share by Application (2021-2032) Figure 55. Asia Equine Drugs and Supplement Revenue Share by Type (2021-2032) Figure 56. Asia Equine Drugs and Supplement Sales Share by Type (2021-2032) Figure 57. Asia Equine Drugs and Supplement Revenue Share by Application (2021-2032) Figure 58. Asia Equine Drugs and Supplement Sales Share by Application (2021-2032) Figure 59. Asia Equine Drugs and Supplement Revenue Share by Country (2021-2032) Figure 60. Asia Equine Drugs and Supplement Sales Share by Country (2021-2032) Figure 61. SAMEA Equine Drugs and Supplement Revenue Share by Type (2021-2032) Figure 62. SAMEA Equine Drugs and Supplement Sales Share by Type (2021-2032) Figure 63. SAMEA Equine Drugs and Supplement Revenue Share by Application (2021-2032) Figure 64. SAMEA Equine Drugs and Supplement Sales Share by Application (2021-2032) Figure 65. SAMEA Equine Drugs and Supplement Revenue Share by Country (2021-2032) Figure 66. SAMEA Equine Drugs and Supplement Sales Share by Country (2021-2032) Figure 67. Equine Drugs and Supplement Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Equine Drugs and Supplement Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotope
  • Radioisotope
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Zoetis
  • Novartis Animal Health
  • Merck Animal Health
  • Bayer Animal Health
  • Merial
  • Elanco (Eli Lilly)
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Equine Drugs and Supplement Market by Type
  3. 1.2.1 Global Equine Drugs and Supplement Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stable Isotope
  5. 1.2.3 Radioisotope
  6. 1.3 Equine Drugs and Supplement Market by Application
  7. 1.3.1 Global Equine Drugs and Supplement Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Laboratory
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Equine Drugs and Supplement Market Dynamics
  1. 2.1 Equine Drugs and Supplement Industry Trends
  2. 2.2 Equine Drugs and Supplement Industry Drivers
  3. 2.3 Equine Drugs and Supplement Industry Opportunities and Challenges
  4. 2.4 Equine Drugs and Supplement Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Equine Drugs and Supplement Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Equine Drugs and Supplement Revenue by Region
  3. 3.2.1 Global Equine Drugs and Supplement Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Equine Drugs and Supplement Revenue by Region (2021-2026)
  5. 3.2.3 Global Equine Drugs and Supplement Revenue by Region (2027-2032)
  6. 3.2.4 Global Equine Drugs and Supplement Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Equine Drugs and Supplement Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Equine Drugs and Supplement Sales by Region
  9. 3.4.1 Global Equine Drugs and Supplement Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Equine Drugs and Supplement Sales by Region (2021-2026)
  11. 3.4.3 Global Equine Drugs and Supplement Sales by Region (2027-2032)
  12. 3.4.4 Global Equine Drugs and Supplement Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Equine Drugs and Supplement Revenue by Manufacturers
  2. 4.1.1 Global Equine Drugs and Supplement Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Equine Drugs and Supplement Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Equine Drugs and Supplement Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Equine Drugs and Supplement Sales by Manufacturers
  6. 4.2.1 Global Equine Drugs and Supplement Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Equine Drugs and Supplement Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Equine Drugs and Supplement Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Equine Drugs and Supplement Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Equine Drugs and Supplement Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Equine Drugs and Supplement Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Equine Drugs and Supplement Manufacturers, Product Type & Application
  13. 4.7 Global Equine Drugs and Supplement Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Equine Drugs and Supplement Market CR5 and HHI
  16. 4.8.2 2025 Equine Drugs and Supplement Tier 1, Tier 2, and Tier 3
5 Equine Drugs and Supplement Market by Type
  1. 5.1 Global Equine Drugs and Supplement Revenue by Type
  2. 5.1.1 Global Equine Drugs and Supplement Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Equine Drugs and Supplement Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Equine Drugs and Supplement Sales by Type
  6. 5.2.1 Global Equine Drugs and Supplement Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Equine Drugs and Supplement Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Equine Drugs and Supplement Sales Market Share by Type (2021-2032)
  9. 5.3 Global Equine Drugs and Supplement Price by Type
6 Equine Drugs and Supplement Market by Application
  1. 6.1 Global Equine Drugs and Supplement Revenue by Application
  2. 6.1.1 Global Equine Drugs and Supplement Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Equine Drugs and Supplement Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Equine Drugs and Supplement Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Equine Drugs and Supplement Sales by Application
  6. 6.2.1 Global Equine Drugs and Supplement Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Equine Drugs and Supplement Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Equine Drugs and Supplement Sales Market Share by Application (2021-2032)
  9. 6.3 Global Equine Drugs and Supplement Price by Application
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Equine Drugs and Supplement Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Novartis Animal Health
  8. 7.2.1 Novartis Animal Health Company Information
  9. 7.2.2 Novartis Animal Health Business Overview
  10. 7.2.3 Novartis Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Animal Health Equine Drugs and Supplement Product Portfolio
  12. 7.2.5 Novartis Animal Health Recent Developments
  13. 7.3 Merck Animal Health
  14. 7.3.1 Merck Animal Health Company Information
  15. 7.3.2 Merck Animal Health Business Overview
  16. 7.3.3 Merck Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Animal Health Equine Drugs and Supplement Product Portfolio
  18. 7.3.5 Merck Animal Health Recent Developments
  19. 7.4 Bayer Animal Health
  20. 7.4.1 Bayer Animal Health Company Information
  21. 7.4.2 Bayer Animal Health Business Overview
  22. 7.4.3 Bayer Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Animal Health Equine Drugs and Supplement Product Portfolio
  24. 7.4.5 Bayer Animal Health Recent Developments
  25. 7.5 Merial
  26. 7.5.1 Merial Company Information
  27. 7.5.2 Merial Business Overview
  28. 7.5.3 Merial Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merial Equine Drugs and Supplement Product Portfolio
  30. 7.5.5 Merial Recent Developments
  31. 7.6 Elanco (Eli Lilly)
  32. 7.6.1 Elanco (Eli Lilly) Company Information
  33. 7.6.2 Elanco (Eli Lilly) Business Overview
  34. 7.6.3 Elanco (Eli Lilly) Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolio
  36. 7.6.5 Elanco (Eli Lilly) Recent Developments
  37. 7.7 Boehringer Ingelheim
  38. 7.7.1 Boehringer Ingelheim Company Information
  39. 7.7.2 Boehringer Ingelheim Business Overview
  40. 7.7.3 Boehringer Ingelheim Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Boehringer Ingelheim Equine Drugs and Supplement Product Portfolio
  42. 7.7.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Equine Drugs and Supplement Market Size by Type
  2. 8.1.1 North America Equine Drugs and Supplement Revenue by Type (2021-2032)
  3. 8.1.2 North America Equine Drugs and Supplement Sales by Type (2021-2032)
  4. 8.1.3 North America Equine Drugs and Supplement Price by Type (2021-2032)
  5. 8.2 North America Equine Drugs and Supplement Market Size by Application
  6. 8.2.1 North America Equine Drugs and Supplement Revenue by Application (2021-2032)
  7. 8.2.2 North America Equine Drugs and Supplement Sales by Application (2021-2032)
  8. 8.2.3 North America Equine Drugs and Supplement Price by Application (2021-2032)
  9. 8.3 North America Equine Drugs and Supplement Market Size by Country
  10. 8.3.1 North America Equine Drugs and Supplement Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Equine Drugs and Supplement Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Equine Drugs and Supplement Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Equine Drugs and Supplement Market Size by Type
  2. 9.1.1 Europe Equine Drugs and Supplement Revenue by Type (2021-2032)
  3. 9.1.2 Europe Equine Drugs and Supplement Sales by Type (2021-2032)
  4. 9.1.3 Europe Equine Drugs and Supplement Price by Type (2021-2032)
  5. 9.2 Europe Equine Drugs and Supplement Market Size by Application
  6. 9.2.1 Europe Equine Drugs and Supplement Revenue by Application (2021-2032)
  7. 9.2.2 Europe Equine Drugs and Supplement Sales by Application (2021-2032)
  8. 9.2.3 Europe Equine Drugs and Supplement Price by Application (2021-2032)
  9. 9.3 Europe Equine Drugs and Supplement Market Size by Country
  10. 9.3.1 Europe Equine Drugs and Supplement Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Equine Drugs and Supplement Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Equine Drugs and Supplement Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Equine Drugs and Supplement Market Size by Type
  2. 10.1.1 China Equine Drugs and Supplement Revenue by Type (2021-2032)
  3. 10.1.2 China Equine Drugs and Supplement Sales by Type (2021-2032)
  4. 10.1.3 China Equine Drugs and Supplement Price by Type (2021-2032)
  5. 10.2 China Equine Drugs and Supplement Market Size by Application
  6. 10.2.1 China Equine Drugs and Supplement Revenue by Application (2021-2032)
  7. 10.2.2 China Equine Drugs and Supplement Sales by Application (2021-2032)
  8. 10.2.3 China Equine Drugs and Supplement Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Equine Drugs and Supplement Market Size by Type
  2. 11.1.1 Asia Equine Drugs and Supplement Revenue by Type (2021-2032)
  3. 11.1.2 Asia Equine Drugs and Supplement Sales by Type (2021-2032)
  4. 11.1.3 Asia Equine Drugs and Supplement Price by Type (2021-2032)
  5. 11.2 Asia Equine Drugs and Supplement Market Size by Application
  6. 11.2.1 Asia Equine Drugs and Supplement Revenue by Application (2021-2032)
  7. 11.2.2 Asia Equine Drugs and Supplement Sales by Application (2021-2032)
  8. 11.2.3 Asia Equine Drugs and Supplement Price by Application (2021-2032)
  9. 11.3 Asia Equine Drugs and Supplement Market Size by Country
  10. 11.3.1 Asia Equine Drugs and Supplement Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Equine Drugs and Supplement Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Equine Drugs and Supplement Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Equine Drugs and Supplement Market Size by Type
  2. 12.1.1 SAMEA Equine Drugs and Supplement Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Equine Drugs and Supplement Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Equine Drugs and Supplement Price by Type (2021-2032)
  5. 12.2 SAMEA Equine Drugs and Supplement Market Size by Application
  6. 12.2.1 SAMEA Equine Drugs and Supplement Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Equine Drugs and Supplement Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Equine Drugs and Supplement Price by Application (2021-2032)
  9. 12.3 SAMEA Equine Drugs and Supplement Market Size by Country
  10. 12.3.1 SAMEA Equine Drugs and Supplement Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Equine Drugs and Supplement Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Equine Drugs and Supplement Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Equine Drugs and Supplement Value Chain Analysis
  2. 13.1.1 Equine Drugs and Supplement Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Equine Drugs and Supplement Production Mode & Process
  6. 13.2 Equine Drugs and Supplement Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Equine Drugs and Supplement Distributors
  9. 13.2.3 Equine Drugs and Supplement Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst